Effect of gamma-immunoglobulin in experimental colitis induced by dextran sulfate

• Published in: Nippon Shōkakibyō Gakkai zasshi Vol. 91; no. 10; p. 1936
• Main Authors: Shintani, N, Nakajima, T, Nakakubo, H, Narita, Y, Nagai, H, Hirao, Y, Watanabe, M, Yokoyama, K, Takizawa, H, Asakura, H
• Format: Journal Article
• Language: Japanese
• Published: Japan 1994
• Subjects: Animals; Colitis, Ulcerative - chemically induced; Colitis, Ulcerative - immunology; Colitis, Ulcerative - therapy; Cytokines - biosynthesis; Dextran Sulfate; Immunoglobulin gamma-Chains - therapeutic use; Immunoglobulins, Intravenous - administration & dosage; Male; Rats; Rats, Wistar
• ISSN: 0446-6586
• DOI: 10.11405/nisshoshi1964.91.1936

To clarify the mechanisms of action of immunoglobulin (IgG) in intravenous immunoglobulin therapy for the ulcerative colitis (UC) patients, we studied the therapeutic effect of IgG on experimental rat colitis induced by dextran sulfate sodium and on the production of inflammatory cytokines such as TNF alpha, IL-1 alpha and IL-8. The administration of rat IgG demonstrated to suppress the development of blood stool and the induction of the ulcerative lesion in large intestine. The levels of TNF alpha, IL-1 alpha and IL-8 were increased in blood and mucosa of the large intestine in this model. Rat IgG showed a tendency to decrease the levels of the cytokines in colonic mucosa. This result seems to provide a piece of explanation of how massive administration of IgG shows an improvement in the ulcerative lesion of UC patients.